Pituitary adenylate cyclase-activating polypeptide (PACAP-38) stimulates rat peritoneal macrophage functions

Peptides

Volumn 17, Issue 7, 1996, Pages 1097-1105

  Delgado, Mario ^a   Garrido, Elvira ^a   De La Fuente, Mónica ^a   Gomariz, Rosa P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

macrophage; phagocytosis; pituitary adenylate cyclase activating polypeptide; superoxide anion production

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROTEIN KINASE INHIBITOR; RETINAL; SUPEROXIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MACROPHAGE; MALE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; NEUROPEPTIDES; PHAGOCYTOSIS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; SUPEROXIDES;

ANIMALIA;

EID: 0029857673     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00171-4     Document Type: Article

References (59)

1. 1. Arimura, A. Pituitary adenylate cyclase activating polypeptide (PACAP): Discovery and current status of research. Regul. Pept. 37:287-303; 1992.
2. 2. Arimura, A.; Somogyvari-Vigh, A.; Weill, C.; Fiore, R. C.; Tatsuno, Y.; Bay, V.; Brenneman, D. E. PACAP functions as a neurotrophic factor. Ann. NY Acad. Sci. 739:228-243; 1994.
3. 3. Bagasra, O.; Howeedy, A.; Kajdacsy-Balla, A. Macrophage function in chronic experimental alcoholism. Modulation of surface receptors and phagocytosis. Immunology 65:405-409; 1988.
4. 4. Bar-Shavit, Z.; Terry, S.; Blumberg, S.; Goldman, R. Neurotensin-macrophage interaction: Specific binding and augmentation of phagocytosis. Neuropeptides 2:325-335; 1982.
5. 5. Basille, M.; Gonzalez, B. J.; Desrues, L.; Demas, M.; Fournier, A.; Vaudry, H. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylyl cyclase and phospholipase C activity in rat cerebellar neuroblasts. J. Neurochem. 65:1318-1324; 1995.
6. 6. Beckner, S. K.; Farrar, W. L. Potentiation of lymphokine-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase. J. Immunol. 140:208-211; 1988.
7. 7. Blalock, J. E. The syntax of immune-neuroendocrine communication. Immunol. Today 15:504-511; 1994.
8. 8. Boige, N.; Aminanoff, B.; Munck, A.; Laburthe, M. Forskolin stimulates adenylate cyclase in human colonie crypts: Interaction with VIP. Eur. J. Pharmacol. 101:111-117; 1984.
9. 9. Bourne, H. C.; Lichtenstein, L. M,; Melmon, K. L.; Henney, C. S.; Weinstein, Y.; Shearer, G. M. Modulation of inflamation and immunity by cyclic AMP. Science 184:19-28; 1974.
10. 10. Cauvin, A.; Robberecht, P.; De Neef, P.; Gourlet, P.; Vandermeers, A.; Vandermeers-Piret, M. C.; Christophe, J. Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord. Regul. Pept. 35:161-173; 1991.
11. 11. Chakder, S.; Rattan, S. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide: Functional and binding studies on opossum internal anal sphincter smooth muscle. J. Pharmacol. Exp. Ther. 266:392-399; 1993.
12. 12. Chaltrer, N.; Tonon, M. C; Vaudry, H.; Conlon, J. M. Primary structure of frog pituitary adenylate cyclase-activating peptide (PACAP) and effects of ovine PACAP on frog pituitary. Endocrinology 129:3367-3371; 1991.
13. 13. Chedeville, A.; Mirossay, L.; Chastre, E.; Hurbain-Kosmath, L.; Lopez, M.; Gespach, C. Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages. FEBS Lett. 319:171-176; 1993.
14. 14. Christophe, J. Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim. Biophys. Acta 1154:183-199; 1993.
15. 15. De la Fuente, M. Changes in the macrophage function with aging. Comp. Biochem. Physiol. [A] 81:935-525; 1985.
16. 16. De la Fuente, M.; Del Rio, M.; Fernandez, M. D.; Hernanz, A. Modulation of phagocytic function in murine peritoneal macrophages by bombesin, gastrin-releasing peptide and neuromedin C. Immunology 73:205-211; 1991.
17. 17. De la Fuente, M.; Bernaez, Y.; Del Rio, M.; Hernanz, A. Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology 80:259-265; 1993.
18. 18. De la Fuente, M.; Delgado, M.; Del Rio, M.; Martinez, C.; Hernanz, A.; Gomariz, R. P. Stimulation by vasoactive intestinal peptide (VIP) of phagocytic function in rat peritoneal macrophages. Protein kinase C involvement. Regul. Pept. 48:347-353; 1993.
19. 19. De la Fuente, M.; Garrido, J. J.; Arahuetes, R. M.; Hernanz, A. Stimulation of pahgocytic function in mouse macrophages by neurotensin and neuromedin N. J. Neuroimmunol. 42:97-104; 1993.
20. 20. De la Fuente, M.; Campos, M.; Del Rio, M.; Hernanz, A. Inhibition of murine peritoneal macrophage functions by sulfated cholecystokinin octapeptide. Regul. Pept. 55:47-56; 1995.
21. 21. Delgado, M.; De la Fuente, M.; Martinez, C.; Gomariz, R.P. Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP-38) inhibit the mobility of murine thymocytes and splenic lymphocytes: Comparison with VIP and implication of cAMP. J. Neuroimmunol. 62:137-146; 1995.
22. + thymocytes from glucocorticoid-induced apoptosis. Blood 87:5152-5161; 1996.
23. 2+]i and inositol phosphates in human neuroblastoma NB-OK-1 cells. Peptides 14:1111-1118; 1993.
24. 24. Deutsch, P. J.; Sun, Y. The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J. Biol. Chem. 267:5108-5113; 1992.
25. 25. Deutsch, P. J.; Schadlos, V. C.; Barzilai, N. 38-Amino acid form of pituitary adenylate cyclase-activating polypeptide induces process outgrowth in human neuroblastoma cells. J. Neurosci. Res. 35:312-320; 1993.
26. 26. Fallman, M.; Lew, D. P.; Stendahl, O.; Andersson, T. Receptor-mediated phagocytosis in human neutrophils is associated with increased formation of inositol phosphates and diacylglycerol. Elevation in cytosolic free calcium and formation of inositol phosphates can be dissociated from accumulation of diacylglycerol. J. Clin. Invest. 84:866; 1989.
27. 27. Gallin, J. I.; Sandler, J. A.; Clyman, R. I.; Manganiello, V. C.; Vaughan, M. Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion. J. Immunol. 120:492-496; 1978.
28. 28. Gaytan, F.; Martinez-Fuentes, A. J.; Garcia-Navarro, F.; Vaudry, H.; Aguilar, E. Pituitary adenylate cyclase-activating peptide (PACAP) immunolocalization in lymphoid tissues of the rat. Cell. Tissue Res. 276:233-277; 1994.
29. 29. Hosoya, M.; Onda, H.; Ogi, K.; Masuda, Y.; Miyamota, Y.; Ohtaki, T.; Okazaki, H.; Arimura, A.; Fujimoto, M. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase-activating polypeptide (PACAP). Biochem. Biophys. Res. Commun. 194:133-143; 1993.
30. 30. Ichinose, M.; Asai, M.; Imai, K,; Sawada, M. Enhancement of phagocytosis in mouse macrophages by pituitary adenylate cyclase activating polypeptide (PACAP) and related peptides. Immunopharmacology 30:217-224; 1995.
31. 31. Ishihara, T.; Shigemoto, R.; Mori, K.; Takahashi, K.; Nagata, S. Functional expression and tissue distribution of a novel receptor for VIP. Neuron 8:811-819; 1992.
32. 2+-dependent stimulatory effect of pituitary adenylate cyclase-activating polypeptide on catecholamine secretion from cultured porcine adrenal medullary chromaffin cells. Endocrinology 132:1757-1765; 1993.
33. 33. Korchak, H. M.; Vosshall, L. B.; Haines, K. A.; Wilkenfeld, C.; Lundquist, K. F.; Weissmann, G. Activation of the human neutrophil by calcium-mobilizing ligands. II. Correlation of calcium, diacylglycerol, and phosphatidic acid generation with superoxide anion generation. J. Biol. Chem. 263:11098-11105; 1988.
34. 34. Kosugi, S.; Okajima, F.; Hidaka, A.; Shenker, A.; Kohn, L. D. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. J. Biol. Chem. 267:24153-24156; 1992.
35. 35. Miyanoshita, A.; Takahashi, T.; Endou, H. Inhibitory effect of cyclic AMP on phorbol ester-stimulated production of reactive oxygen metabolites in rat glomeruli. Biochem. Biophys. Res. Commun. 165:519-525; 1989.
36. 36. Miyata, A.; Arimura, A.; Dahl, R.R.; Minamino, N.; Uehara, A.; Jiang, L.; Culler, M.; Coy, D. H. Isolation of a novel 38 residue-hypothalamic polypeptide which simulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164:567-574; 1989.
37. 37. Morotti, T.; Haberstok, H.; Sverko, V.; Hrsak, Y. Met- and Leuenkephalin modulate superoxide anion release from human polymorphonuclear cells. Ann. NY Acad. Sci. 650:146-149; 1992.
38. 38. Nishizuka, Y. Studies and perspectives of protein kinase C. Science 233:305-308; 1986.
39. 39. Ottaway, C. A. Receptors for vasoactive intestinal peptide on murine lymphocytes turn over rapidly. J. Neuroimmunol. 38:241-254; 1992.
40. 2+ efflux in human breast cancer cells by bombesin. Cancer Res. 50:235-239; 1990.
41. 41. Pisegna, J. R.; Wank, S. A. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc. Natl. Acad. Sci. USA 90:6345-6349; 1993.
42. 42. Pryzwansky, K. B.; Stainer, A. L.; Spitznagel, J. K.; Kapoor, C. L. Compartmentalization of cyclic AMP during phagocytosis by human neutrophilic granulocytes. Science 211:407-410; 1981.
43. i in rat gonadotrophs through an inositol triphosphate-dependent mechanism. J. Biol. Chem. 269:5680-5686; 1994.
44. 44. Rodriguez-Pena, M. S.; Guijarro, L. G.; Prieto, J. C. Vasoactive intestinal peptide receptor antagonist in rat seminal vesicle membranes. Eur. J. Pharmacol. 208:207-212; 1991.
45. 45. Segura, J. J.; Guerrero, J. M.; Gobérna, R.; Calvo, J. R. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages. Regul. Pept. 33:133-143; 1991.
46. 46. Shivers, B. D.; Göres, T. J.; Gottschall, P. E.; Arimura, A. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology 128:3055-3065; 1991.
47. 47. Spengler, D.; Waeber, C.; Pantaloni, C.; Holsboer, F.; Bockaert, J.; Seeburg, P. H.; Journot, L. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-175; 1993.
48. 48. Taffet, S. M.; Greenfield, A. R. L.; Haddox, M. K. Retinal inhibits TPA activated calcium-dependent, phospholipid-dependent protein kinase C. Biochem. Biophys. Res. Commun. 114:1194-1199; 1983.
49. 49. Tatsuno, I.; Gottschall, P. E.; Arimura, A. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase-activating polypeptide: a comparative study with vasoactive intestinal peptide. Endocrinology 128:728-734; 1991.
50. 50. Unanue, E. R. Macrophages, antigen-presenting cells, and the phenomena of antigen handling and presentation. In: Paul, W.E., ed. Fundamental immunology. New York: Raven Press; 1989:95-115.
51. 51. Unanue, E.; Allen, P. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236:551-557; 1987.
52. 2 as a VIP antagonist. Endocrinology 116:2643-2649; 1985.
53. 53. Walker, B. A. M.; Hagenlocker, B. E.; Ward, P. A. Superoxide responses to formyl-methionul-leucyl-phenylalanine in primed neutrophils. Role of intracellular and extracellular calcium. J. Immunol. 146:3124-3131; 1991.
54. 54. Wiik, P. Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism. Regul. Pept. 25:187-197; 1989.
55. 55. Wiik, P.; Haugen, A.; Lovhaug, D.; Boyum, A.; Opstad, P. K. Effect of VIP on the respiratory burst in human monocytes ex vivo during prolonged strain and energy deficiency. Peptides 10:819-823; 1989.
56. 56. Wirth, J. J.; Kierszenbaum, F. Inhibitory action of elevated levels of adenosine-3′:5′ cyclic monophosphate on phagocytosis: Effects on macrophage-trypanosoma cruzi interaction. J. Immunol. 129:2759-2762; 1982.
57. 57. Wozniak, A.; Scicchitano, R.; Betts, W. H.; McLennan, G. The effect of substance P on normal and asthmatic subjects. Ann. NY Acad. Sci. 650:154-159; 1992.
58. 58. Young, L. D. E.; Ko, S. S.; Cohn, Z. A. The increase in intracellular free calcium associated with IgG 2b/1 Fc receptor-ligand interactions: Role in phagocytosis. Proc. Natl. Acad. Sci. USA 81:5430-5434; 1984.
59. 59. Yu, S. S.; Lefkowitz, R. J.; Hausdorff, W. P. Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J. Biol. Chem. 268:337-341; 1993.